• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Crescita Therapeutics Inc (TSX:CTX)

0.7900 UNCHANGED
Last Price Updated: 9:30 AM EDT, Jun 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.7900
Bid (Size) 0.7900 (4,095)
Ask (Size) 0.8000 (1,650)
Prev. Close 0.7900
Today's Range 0.7900 - 0.7900
52wk Range 0.4000 - 0.7900
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Crescita Therapeutics Inc. Announces Closing of Arrangement
June 03, 2026
From Crescita Therapeutics Inc.
Via Business Wire
News headline image
Crescita Therapeutics Inc. Announces Final Consideration Payable to Shareholders Pursuant to Arrangement with ClinActiv
June 01, 2026
From Crescita Therapeutics Inc.
Via Business Wire

Performance

52-Week Range
0.7900
0.4052W Low 0.7952W High

Crescita Therapeutics Inc (CTX) traded between $0.40 and $0.79 over the past 52 weeks and last traded at $0.79.

Past 12 Months
N/A
N/A
N/A
+3.9%
+61.2%
+79.5%
1W  
1M  
3M  
6M +$0.03
YTD +$0.30
1Y +$0.35

CTX was +79.5% over the past year, +3.9% over six months, +61.2% year to date.

12 Months vs Market
CTX
+79.5%
DIA
+12.4%
SPY
+12.5%
QQQ
+10.3%
IWM
+15.8%

Over the past 12 months CTX returned +79.5% versus DIA (Dow) +12.4%, SPY (S&P 500) +12.5%, QQQ (Nasdaq 100) +10.3% and IWM (Russell 2000) +15.8%.

Volume & Liquidity
6M
16.7K
YTD
35.2K
1Y
34.5K

More News

Read More
News headline image
Crescita Therapeutics Inc. Obtains Final Order Approving Plan of Arrangement
May 20, 2026
From Crescita Therapeutics Inc.
Via Business Wire
News headline image
Crescita Obtains Shareholder Approval To Be Acquired By ClinActiv Holdings
May 14, 2026
From Crescita Therapeutics Inc.
Via Business Wire
News headline image
Crescita Reports First Quarter 2026 Results
May 11, 2026
From Crescita Therapeutics
Via Business Wire
News headline image
Crescita Announces Filing and Mailing of Special Meeting Materials and Receipt of Interim Order in respect of Arrangement with ClinActiv Holdings
April 22, 2026
From Crescita Therapeutics Inc.
Via Business Wire
News headline image
Crescita Reports Q4 and Fiscal 2025 Results
March 31, 2026
From Crescita Therapeutics Inc.
Via Business Wire
News headline image
Crescita Announces Definitive Agreement to Be Acquired by ClinActiv Holdings in an All-Cash Transaction at a Significant Premium
March 16, 2026
From Crescita Therapeutics Inc.
Via Business Wire
News headline image
Crescita Reports Third Quarter 2025 Results
November 05, 2025
From Crescita Therapeutics Inc.
Via Business Wire
News headline image
Crescita Reports Second Quarter 2025 Results
August 06, 2025
From Crescita Therapeutics Inc.
Via Business Wire
News headline image
Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders
June 05, 2025
From Crescita Therapeutics Inc.
Via Business Wire
News headline image
Crescita Therapeutics Announces Mutual Termination of Licensing Agreement with Croma Pharma GmbH for Pliaglis®
May 23, 2025
From Crescita Therapeutics
Via Business Wire
News headline image
Crescita Reports First Quarter 2025 Results
May 14, 2025
From Crescita Therapeutics Inc.
Via Business Wire
News headline image
Crescita Reports Q4 and Fiscal 2024 Results
March 18, 2025
From Crescita Therapeutics
Via Business Wire
News headline image
Crescita Reports Third Quarter 2024 Results
November 06, 2024
From Crescita Therapeutics
Via Business Wire
News headline image
Crescita Therapeutics Announces Approval of Normal Course Issuer Bid
September 24, 2024
From Crescita Therapeutics
Via Business Wire
News headline image
Keynotes and 50 Companies to Present at the Planet MicroCap Showcase: VANCOUVER in association with Small Cap Discoveries on September 25-26, 2024 at the Fairmont Waterfront Vancouver
September 24, 2024
Via ACCESSWIRE
News headline image
Crescita to Present & Participate in 1x1 Meetings at the Planet MicroCap Showcase: VANCOUVER 2024 in Association with Small Cap Discoveries on Thursday, September 26, 2024
September 12, 2024
From Crescita Therapeutics
Via Business Wire
News headline image
Crescita Reports Second Quarter 2024 Results
August 07, 2024
From Crescita Therapeutics
Via Business Wire
News headline image
Crescita Secures Contract Manufacturing Revenue of $US10 Million Over 4 Years
July 22, 2024
From Crescita Therapeutics
Via Business Wire
News headline image
Leading Canadian Healthcare Services Provider Selects Crescita as Exclusive Manufacturing Partner under 5-Year Agreement
July 19, 2024
From Crescita Therapeutics
Via Business Wire
News headline image
Crescita Expands Medical Aesthetic Portfolio with MicronJetTM600 The World’s Smallest Intradermal Delivery Device
July 17, 2024
From Crescita Therapeutics
Via Business Wire
News headline image
Crescita Completes Acquisition of Strategic Assets of Occy Laboratory
June 26, 2024
From Crescita Therapeutics
Via Business Wire
News headline image
Crescita to Acquire Strategic Assets of Occy Laboratory
June 20, 2024
From Crescita Therapeutics
Via Business Wire
News headline image
Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders
June 06, 2024
From Crescita Therapeutics
Via Business Wire

Frequently Asked Questions

Is Crescita Therapeutics Inc publicly traded?
Yes, Crescita Therapeutics Inc is publicly traded.
What exchange does Crescita Therapeutics Inc trade on?
Crescita Therapeutics Inc trades on the Toronto Stock Exchange
What is the ticker symbol for Crescita Therapeutics Inc?
The ticker symbol for Crescita Therapeutics Inc is CTX on the Toronto Stock Exchange
What is the current price of Crescita Therapeutics Inc?
The current price of Crescita Therapeutics Inc is 0.7900
When was Crescita Therapeutics Inc last traded?
The last trade of Crescita Therapeutics Inc was at 06/04/26 09:30 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap